People with lung problems such as asthma and chronic obstructive pulmonary disease (COPD) face even larger risks from climate change, according to a research.
According to an expert analysis published in the European Respiratory Journal, people with lung disorders such as asthma and chronic obstructive pulmonary disease (COPD) suffer even greater risks from climate change.
When an immunocompromised person's system starts to heal and create more white blood cells, it's usually a healthy sign - unless they acquire a potentially fatal inflammatory condition. According to new research from the University of Illinois Urbana-Champaign, the pulmonary distress commonl
In order to expedite treatment for critically ill patients, a study headed by Nalinikanth Kotagiri of the University of Cincinnati seeks to create a new imaging technique that can recognize specific types of lung infections in real time.
According to a study published in ERJ Open Research, patients with low levels of vitamin K in their blood are more likely to have reduced lung function and suffer from asthma, chronic obstructive pulmonary disease (COPD), and wheezing.
People with low levels of vitamin K in their blood are more likely to have reduced lung function and to suffer from asthma, chronic obstructive pulmonary disease (COPD), and wheezing, according to a study.
According to a study published in ERJ Open Research people with low levels of vitamin K in their blood are more likely to have impaired lung function and to suffer from asthma, chronic obstructive pulmonary disease (COPD), and wheezing.
London [UK]/ Seattle (Washington) [US], June 29: Wellcome and the Bill & Melinda Gates Foundation today announced funding to advance a tuberculosis (TB) vaccine candidate, M72/AS01E (M72), through a Phase III clinical trial. If proven effective, M72 could potentially become the first new
Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab.
New Delhi [India], June 19: The Institute of Heart Lungs Diseases & Research Centre (IHLD) will soon open in the country's national capital, New Delhi. One of the premier institutes in North India, IHLD will be among the few institutes in the country offering specialised healthcare servi
Bronchodilators known as beta-2 agonists are extensively used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Although beta-2 agonists have been linked to a lower incidence of Parkinson's disease in earlier research, this link was not detected in a recent registe
Gurugram (Haryana) [India], May 26: HCAH, India's leading out-of-hospital care provider, announces its collaboration with fourteen major insurance players, becoming the first transition care provider in India to make insurance available for its patients. This is a significant milestone fo